Biocon shares fall after July-Sept earnings

Reuters Market Eye - Biocon Ltd falls 2.7 percent. July-Sept earnings lag some analyst estimates.

Margins contracted by 90 bps to 22.8 percent are on account of higher employee costs.

Biocon says biopharma business continues to be impacted by factors like geo-political challenges.

(Reporting by Abhishek Vishnoi)